Patients operated on during the luteal phase (days 15-32) had a trend towards a better survival rate (80.4%) than those treated in the follicular phase (days 1-14) (75.9%), but the difference did not reach statistical significance (P = 0.079).
← all excerpts
Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient--fact or fallacy.
1
0.0790
0.0790